GB0605265D0 - Virus-like particles of rift valley fever virus - Google Patents

Virus-like particles of rift valley fever virus

Info

Publication number
GB0605265D0
GB0605265D0 GBGB0605265.8A GB0605265A GB0605265D0 GB 0605265 D0 GB0605265 D0 GB 0605265D0 GB 0605265 A GB0605265 A GB 0605265A GB 0605265 D0 GB0605265 D0 GB 0605265D0
Authority
GB
United Kingdom
Prior art keywords
virus
particles
valley fever
rift valley
fever virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0605265.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
London School of Hygiene and Tropical Medicine
Original Assignee
London School of Hygiene and Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by London School of Hygiene and Tropical Medicine filed Critical London School of Hygiene and Tropical Medicine
Priority to GBGB0605265.8A priority Critical patent/GB0605265D0/en
Publication of GB0605265D0 publication Critical patent/GB0605265D0/en
Priority to PCT/GB2007/000889 priority patent/WO2007104979A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12211—Phlebovirus, e.g. Rift Valley fever virus
    • C12N2760/12222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12211—Phlebovirus, e.g. Rift Valley fever virus
    • C12N2760/12223—Virus like particles [VLP]
GBGB0605265.8A 2006-03-15 2006-03-15 Virus-like particles of rift valley fever virus Ceased GB0605265D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0605265.8A GB0605265D0 (en) 2006-03-15 2006-03-15 Virus-like particles of rift valley fever virus
PCT/GB2007/000889 WO2007104979A1 (en) 2006-03-15 2007-03-14 Virus-like particles of rift valley fever virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0605265.8A GB0605265D0 (en) 2006-03-15 2006-03-15 Virus-like particles of rift valley fever virus

Publications (1)

Publication Number Publication Date
GB0605265D0 true GB0605265D0 (en) 2006-04-26

Family

ID=36292844

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0605265.8A Ceased GB0605265D0 (en) 2006-03-15 2006-03-15 Virus-like particles of rift valley fever virus

Country Status (2)

Country Link
GB (1) GB0605265D0 (en)
WO (1) WO2007104979A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2133358A1 (en) * 2008-06-10 2009-12-16 Universitätsklinikum Freiburg Rift valley fever virus-like particles and their use for immunization and as test system
GB0820631D0 (en) * 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors
CN114409769B (en) * 2019-02-15 2023-05-09 中国科学院微生物研究所 Setaria fever virus humanized monoclonal antibody and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735800A (en) * 1983-09-09 1988-04-05 Molecular Genetics, Inc. Vaccines against rift valley fever virus
WO2004042001A2 (en) * 2002-05-17 2004-05-21 Emory University Virus-like particles, methods of preparation, and immonogenic compositions
EP1732615A4 (en) * 2004-03-25 2009-09-16 Kentucky Bioproc Llc Production of peptides in plants as viral coat protein fusion
ZA200610012B (en) * 2005-11-30 2009-03-25 Univ Texas Reverse genetic system for Rift Valley fever virus and uses thereof

Also Published As

Publication number Publication date
WO2007104979A1 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
HK1138795A1 (en) Virus like particle purification
EP1885394A4 (en) Production of multivalent virus like particles
EP2035565A4 (en) Methods of enhancing protein incorporation into virus like particles
HK1121687A1 (en) Functional influenza virus like particles (vlps) (vlp)
ZA201004478B (en) Antibodies against influenza virus and methods of use thereof
IL247417A0 (en) The use of solid carrier particles to improve the processability of a pharmaceutical agent
EP2370455A4 (en) Virus like particle compositions and methods of use
EP2044198A4 (en) Chimeric influenza virus-like particles
EP2152730A4 (en) Enhancement of glycoprotein incorporation into virus-like particles
AP2009005057A0 (en) Novel peptide inhibitors of hepatitis c virus replication
PL2589602T3 (en) Development of dengue virus vaccine components
ZA200706111B (en) Production and use of polysilicate particulate materials
IL222997A0 (en) Soluble fragments of influenza virus pb2 protein capable of binding rna - cap
EP2118323A4 (en) Detection of influenza virus
HK1112846A1 (en) Canine influenza virus and related compositions and methods of use
EP2186893A4 (en) Production and use of epitope-tagged hepatitis c virus particle
EP1931698A4 (en) Rapid production of high titer virus
ZA200809056B (en) Influenza virus vaccine
AP2010005331A0 (en) Recombinant rift valley fever (RVF) viruses and methods of use
EP2049662A4 (en) Methods and compositions for increasing replication capacity of an influenza virus
ZA201008746B (en) Rift valley fever virus-like particles and their use for immunization and as test system
GB0605265D0 (en) Virus-like particles of rift valley fever virus
GB0714223D0 (en) Preparation of fine particles
HK1222553A1 (en) The use of solid carrier particles to improve the processability of a pharmaceutical agent
TWI349566B (en) A kind of chitosan particles is capable for virus adsorption

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)